Anaerobic bacteria infectious disease
MONDO:0024389Also known as: anaerobic bacterial infection, infection caused by anaerobic bacteria, infection due to anaerobic bacteria
90 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New tetanus vaccine enters first human safety tests
⭐️ VACCINE ⭐️ OngoingThis early-stage trial is testing a new tetanus vaccine in 80 adults aged 18 and older. The study is randomized and double-blind, meaning neither participants nor doctors know who gets the new vaccine versus an existing one. The main goal is to check for side effects within the f…
Phase: PHASE1 • Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 16, 2026 00:00 UTC
-
New infant vaccine aims to shield against three serious diseases
⭐️ VACCINE ⭐️ OngoingThis phase 3 study tests a new vaccine (DTacP) that protects infants from diphtheria, tetanus, and whooping cough. Around 2,900 healthy babies aged 2-3 months will receive the vaccine to check its safety and how well it triggers immunity. The trial compares different schedules an…
Phase: PHASE3 • Sponsor: China National Biotec Group Company Limited • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:26 UTC
-
New booster vaccine trial aims to shield japanese teens from three serious diseases
Disease control OngoingThis study tests a single booster dose of a combined vaccine against diphtheria, tetanus, and whooping cough (dTpa) in 85 healthy Japanese adolescents aged 11 to 13. Researchers will check if the shot triggers a strong immune response and monitor for side effects one month after …
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 18, 2026 04:00 UTC
-
New tetanus shot enters human safety testing
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests a new lab-made antibody injection against tetanus in 68 healthy adults aged 18-60. The main goal is to check safety and side effects, not to treat or prevent tetanus directly. Participants receive a single shot and are monitored for several weeks.
Phase: PHASE1 • Sponsor: Lanzhou Institute of Biological Products Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study checks if botulism antidote is safe and effective for kids
Disease control ENROLLING_BY_INVITATIONThis study looks at how a medicine called BAT® works in children who have or may have been exposed to botulism toxin. The medicine is an antitoxin that helps stop the toxin from causing more harm. Researchers will take blood samples from up to 10 children to see if the dose is ri…
Phase: PHASE4 • Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug aims to stop dangerous gut infection from returning
Prevention OngoingThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infection from coming back after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more pe…
Phase: PHASE2, PHASE3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Old drug, new trick: vancomycin may stop c. diff before it starts
Prevention TerminatedThis study tests whether taking oral vancomycin alongside other antibiotics can prevent Clostridioides difficile infection (C. diff) in people aged 65 and older. Participants are randomly assigned to receive either vancomycin or standard care. The goal is to see if the drug reduc…
Phase: PHASE2, PHASE3 • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jul 31, 2026 00:00 UTC
-
Do vaccines still work during lymphoma treatment? new study aims to find out
Knowledge-focused OngoingThis study tracks 56 follicular lymphoma patients to see how long their COVID-19 and other vaccine immunity lasts while they receive chemotherapy and maintenance therapy. Researchers will collect blood samples at several time points to measure immune responses. The goal is to und…
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New database aims to speed up FMT research for gut infections
Knowledge-focused TerminatedThis study screens adults interested in fecal microbiota transplant (FMT) for Clostridium difficile infection. Researchers will collect medical information and run basic health tests to create a database of potential participants. The goal is to make it faster and easier to enrol…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Hospital maps may slash infection spread
Knowledge-focused OngoingThis study tests a computer tool that uses maps and location data to help infection preventionists find and stop hospital-acquired infections faster. About 25 infection prevention staff will use the tool and report how easy it is to use and whether it helps them respond more quic…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC